ArticlePharmaceuticals (Basel, Switzerland)2022

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Ana Matošević et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.